Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Rotter

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|February 29, 2024
Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a single center studyFrederic Jungbauer, Annette Affolter, Christoph Brochhausen, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2025
Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response RateLena Huber, Constanze Kohler, Anne Lammert, et al.
Cancers|July 13, 2024
C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCCFrederic Jungbauer, Claudia Scherl, Nicole Rotter, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 9, 2026
Awareness of Head and Neck Cancer, its Risk Factors, and of Human Papillomavirus-A Survey StudyTheresa Obermueller, Sarah Volpe, Denitze Lara Escobar, et al.
Applied Microbiology and Biotechnology|May 29, 2014
Biocompatibility evaluation of densified bacterial nanocellulose hydrogel as an implant material for auricular cartilage regenerationHéctor Martínez Ávila, Silke Schwarz, Eva-Maria Feldmann, et al.
Anticancer Research|July 26, 2024
Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFβ1 and TGF-β Receptor 2 in Squamous Cell Carcinoma CellsLena Huber, Manuel Thomas Knüttel, Benedikt Kramer, et al.
Advanced Healthcare Materials|January 13, 2025
3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) BioinkAlexya Azhakesan, Johann Kern, Ankit Mishra, et al.
Journal of Biomedical Materials Research. Part A|December 30, 2021
Modulation of the inflammatory response to decellularized collagen matrix for cartilage regenerationDavid Gvaramia, Johann Kern, Yvonne Jakob, et al.
Experimental and Therapeutic Medicine|August 18, 2022
An <i>in vitro</i> study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasiaHaneen Sadick, Elena Schäfer, Christel Weiss, et al.
Tissue Engineering|March 2, 2005
Role for interleukin 1alpha in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffoldsNicole Rotter, Feodor Ung, Amit K Roy, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|February 29, 2024
Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a single center studyFrederic Jungbauer, Annette Affolter, Christoph Brochhausen, et al.
Cancer Reports (Hoboken, N.J.)|November 11, 2025
Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response RateLena Huber, Constanze Kohler, Anne Lammert, et al.
Cancers|July 13, 2024
C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCCFrederic Jungbauer, Claudia Scherl, Nicole Rotter, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 9, 2026
Awareness of Head and Neck Cancer, its Risk Factors, and of Human Papillomavirus-A Survey StudyTheresa Obermueller, Sarah Volpe, Denitze Lara Escobar, et al.
Applied Microbiology and Biotechnology|May 29, 2014
Biocompatibility evaluation of densified bacterial nanocellulose hydrogel as an implant material for auricular cartilage regenerationHéctor Martínez Ávila, Silke Schwarz, Eva-Maria Feldmann, et al.
Anticancer Research|July 26, 2024
Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFβ1 and TGF-β Receptor 2 in Squamous Cell Carcinoma CellsLena Huber, Manuel Thomas Knüttel, Benedikt Kramer, et al.
Advanced Healthcare Materials|January 13, 2025
3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) BioinkAlexya Azhakesan, Johann Kern, Ankit Mishra, et al.
Journal of Biomedical Materials Research. Part A|December 30, 2021
Modulation of the inflammatory response to decellularized collagen matrix for cartilage regenerationDavid Gvaramia, Johann Kern, Yvonne Jakob, et al.
Experimental and Therapeutic Medicine|August 18, 2022
An <i>in vitro</i> study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasiaHaneen Sadick, Elena Schäfer, Christel Weiss, et al.
Tissue Engineering|March 2, 2005
Role for interleukin 1alpha in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffoldsNicole Rotter, Feodor Ung, Amit K Roy, et al.
Pageof 17